Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Cancer Discovery|November 23, 2018
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancersJoshua D Cohen, Ammar A Javed, Christopher Thoburn, et al.
Cancer Discovery|November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerYelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Pageof 9